Skip to main content

Animations

MJFF Publications

4301 - 4310 of 9016 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2012
  • 2012
  • 2010
  • 2018
  • 2017
  • 2021
  • 2024
  • 2018
  • Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA
    2016
    Summary Details
    RESTRICTED
    Title: Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA
    Journal Name: Analytical and Bioanalytical Chemistry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00216-016-9863-7
    Citation Count: 29
  • Summary Details
    OPEN
    Title: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital age
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27673
    Citation Count: 61
  • Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
    2012
    Summary Details
    RESTRICTED
    Title: Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
    Journal Name: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbapap.2011.12.009
    Citation Count: 26
  • P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    2012
    Summary Details
    RESTRICTED
    Title: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296
    Citation Count: 0
  • Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective
    2010
    Summary Details
    RESTRICTED
    Title: Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/bmm.10.89
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27342
    Citation Count: 54
  • Summary Details
    OPEN
    Title: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awx378
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddae018
    Citation Count: 3
  • Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor
    2018
    Summary Details
    RESTRICTED
    Title: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.